# Effect of Simeox® on Residual Volume in COPD Patients With Pulmonary Hyperinflation

> **NCT07665931** · NA · RECRUITING · sponsor: **Azienda Socio Sanitaria Territoriale di Lodi** · enrollment: 23 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)
- Pulmonary Hyperinflation

## Interventions

- **DEVICE:** Simeox

## Key facts

- **NCT ID:** NCT07665931
- **Lead sponsor:** Azienda Socio Sanitaria Territoriale di Lodi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-05
- **Primary completion:** 2026-09
- **Final completion:** 2026-12
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2026-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07665931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07665931, "Effect of Simeox® on Residual Volume in COPD Patients With Pulmonary Hyperinflation". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07665931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*